Vyvanse has been approved by the Food and Drug Administration to treat Attention Deficit Hyperactivity Disorder (ADHD) for children six years old to twelve years old. This medication has not been tested in children under the age of six and should not be given to children five and under.
Vyvanse is a short acting medication Normally, the first dose of Vyvanse is taken first thing in the morning. Additional doses can...Read more
It's finally here! Merck's patent on the popular osteoporosis drug Fosamax has run out, and now other companies are offering generic... Read more »
I had always been told that the active ingredients in generic medications had to be exactly the same as their brand name counterparts; that... Read more »
A five-member majority of the U. S. Supreme Court concluded in late June that "it makes little sense" to bar suits against generic... Read more »
I've got a case of the wonders. Multiple sclerosis is an elusive force, but with a powerful impact on daily living, it is rife with... Read more »
Are you willing to change pharmacies to save money on prescription drugs? With Wal-Mart stores in 49 states now offering $4 generic prescription... Read more »
The FDA recently approved two new generic versions of Boehringer Ingelheim Pharmaceuticals Inc.'s popular anti-arthritis medication, Mobic. This... Read more »